The 20 Best Status Epilepticus Doctors near Bronx, NY

Shlomo Shinnar is a Pediatric Neurologist in Bronx, New York. Dr. Shinnar is rated as an Elite provider by MediFind in the treatment of Status Epilepticus. His top areas of expertise are Genetic Epilepsy with Febrile Seizures Plus (GEFS+), Status Epilepticus, Seizures, and Epilepsy.

Jan Claassen is a Neurologist in New York, New York. Dr. Claassen is rated as an Elite provider by MediFind in the treatment of Status Epilepticus. His top areas of expertise are Subarachnoid Hemorrhage, Status Epilepticus, Seizures, Stroke, and Thrombectomy. Dr. Claassen is currently accepting new patients.

Solomon L. Moshé, MD, is Vice Chair of Neurology, Director of the Isabelle Rapin Child Neurology Division and Director of Clinical Neurophysiology at Montefiore. He is also the Charles Frost Chair in Neurosurgery and Neurology, Vice Chair, Saul R. Korey Department of Neurology, and Professor of Neurology, Neuroscience and Pediatrics at the Albert Einstein College of Medicine (Einstein). Dr. Moshé’s clinical focus is on epilepsy and electroencephalography with special emphasis on age-related influences on the expression, control and consequences of seizures. Dr. Moshe is rated as a Distinguished provider by MediFind in the treatment of Status Epilepticus. His top areas of expertise are West Syndrome, Spasmus Nutans, Post-Traumatic Epilepsy, and Epilepsy.

Dr. Alexis D. Boro coordinates the Epilepsy Surgery program at Montefiore Medical Center and oversees epilepsy fellowship education and the epilepsy clinical trials program. He has been an Investigator for studies involving the safety, tolerability and efficacy of a variety of epilepsy drugs. He is a co-investigator (EEG Core) of the Epilepsy Phenome/Genome Project, an international NIH funded project investigating the causes and inheritance of epilepsy and the determinants which anti-seizure medications will work best for a given individual. Dr. Boro is rated as an Advanced provider by MediFind in the treatment of Status Epilepticus. His top areas of expertise are Seizures, Epilepsy, Memory Loss, and Autosomal Dominant Partial Epilepsy with Auditory Features.

Dr. Sheryl Haut is Director of the Adult Epilepsy Program at Montefiore. She has extensive experience treating all forms of epilepsy in young and older adults, and in tailoring treatments to the individual. She focuses on special needs such as pregnancy, stress, driving, work related issues, and issues in the elderly. Dr. Haut has an extensive research background, including a Masters of Clinical Research with Distinction from Albert Einstein College of Medicine. Her research interests focus on seizure clustering; seizure prediction and pre-emption; and alternative therapies for epilepsy. She is one of the first investigators to run a clinical trial of stress management for epilepsy, using smartphone diaries. Dr. Haut is the current Chair of the North American Commission of the International League Against Epilepsy, and is active nationally in the American Epilepsy Society, and the American Academy of Neurology, serving on committees of both organizations. She has authored more than 50 papers/book chapters on epilepsy, and has been featured in Top Doctors of NY annually since 2009. She maintains an active adult epilepsy practice at the Moses Campus. Dr. Haut is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. Her top areas of expertise are Seizures, Epilepsy, Absence Seizure, and Generalized Tonic-Clonic Seizure.

Jillian L. Rosengard, MD, is an attending physician and Associate Professor of Neurology at Montefiore Einstein. She specializes in the diagnosis and management of seizures and epilepsy. She has a particular interest in treating patients with intractable epilepsy and caring for women with epilepsy during their pregnancies, as well as medical education. Dr. Rosengard is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. Her top areas of expertise are Seizures, Generalized Tonic-Clonic Seizure, Epilepsy, and Memory Loss.

Jisoon Kim is a Neurologist in Bronx, New York. Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. Her top areas of expertise are Stroke, Generalized Tonic-Clonic Seizure, Seizures, Status Epilepticus, and Gastrostomy.

Elissa G. Yozawitz, MD, is Director of Neonatal Neurology at Children’s Hospital at Montefiore Einstein and Professor of Neurology and Pediatrics at our Albert Einstein College of Medicine. Dr. Yozawitz focuses on the neurological management of children, from the neonatal period through adolescence, particularly those with difficult-to-treat seizures. She also specializes in the diagnosis and treatment of hypoxic-ischemic encephalopathy, stroke and seizures in the newborn. Dr. Yozawitz’s expertise includes electroencephalography (EEG) and state-of-the-art treatments. Dr. Yozawitz is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. Her top areas of expertise are West Syndrome, Epilepsy in Children, Spasmus Nutans, and Epilepsy.

Madeline Fields is a Neurologist in New York, New York. Dr. Fields is rated as a Distinguished provider by MediFind in the treatment of Status Epilepticus. Her top areas of expertise are Seizures, Epilepsy, Generalized Tonic-Clonic Seizure, Partial Familial Epilepsy, and Deep Brain Stimulation.

"Tristan T. Sands, MD, PhD is Assistant Professor in the Columbia University Vagelos College of Physicians & Surgeons (Columbia VP&S) Departments of Neurology and Pediatrics. He is a pediatric neurologist who treats children and babies suffering from epilepsy and a physician scientist with expertise in genetic causes of epilepsy and neurodevelopmental disease. Dr. Sands completed his MD-PhD at Columbia VP&S through a Medical Scientist Training Program with thesis work in lab of Dr. Arnold Kriegstein. During child neurology residency at UCSF, Dr. Sands trained in electroclinical phenotyping of the epilepsies under Dr. M. Roberta Cilio. After finishing his clinical training at Columbia VP&S in epilepsy and clinical neurophysiology with Dr. Jim Riviello, Dr. Sands joined Columbia VP&S as faculty in 2017, first training in neurogenetics at the Institute for Genomic Medicine, and then returning to the bench to study genetic epilepsy using mouse models under the mentorship of Dr. Wayne Frankel. Dr. Sands has worked closely with families to treat hundreds of children with epilepsy. He is the author of chapters on pediatric epilepsy and genetic epilepsy in major textbooks in the field of neurology, including Merritt’s Neurology and Swaiman’s Pediatric Neurology. Dr. Sands has served as an expert on ClinGen’s epilepsy gene curation panel since 2017. In 2023, Dr. Sands was named Fellow of the American Epilepsy Society in recognition of professional accomplishment and dedication in the field of epilepsy. Dr. Sands is a 2024 Louis V. Gerstner Scholar. His research contributions include demonstration of the exquisite efficacy of carbamazepine for neonatal epilepsy caused by inherited loss-of-function variants in KCNQ2 and KCNQ3, work that led to changes to the International League against Epilepsy guidelines and recommendations on the treatment of seizures in newborn babies. Dr. Sands reported the electroclinical characterization of a new gain-of-function phenotype caused by de novo variants in KCNQ3. Dr. Sands reported variants in NBEA as a cause epilepsy and neurodevelopment, and he characterized the largest cohort of patients with epilepsy and neurodevelopmental disability caused by pathogenic variants in CSNK2B. The Sands ""END (Epilepsy & Neurodevelopmental Disease) Laboratory,"" established in 2022 in the Center for Translational Research in Neurodevelopmental Disease (CTRND), uses mouse and human cellular models to identify convergent disease mechanisms and novel therapeutic strategies for epilepsy and encephalopathy caused by rare genetic mutations. These research efforts are supported by federal grants from both NIH and private agencies.". Dr. Sands is rated as an Advanced provider by MediFind in the treatment of Status Epilepticus. His top areas of expertise are Epilepsy in Children, Epilepsy, Seizures, and Status Epilepticus.

The maturation of GABAA receptor-mediated signaling from depolarizing to inhibitory is an age-related process controlled by cation chloride cotransporters, such as KCC2. As a result, GABA exerts dual functions, being an important neurotrophic factor during early development and the principal inhibitory neurotransmitter of the mature central nervous system. In our laboratory we have been investigating the age and mechanisms through which early life stressors and seizures may disrupt the normal patterns of brain development, by disrupting the neurotrophic effects of GABA. We are also studying methods to reverse these adverse processes. Furthermore, we are very interested in understanding how epileptogenesis proceeds in the developing brain and what is the specific role of GABAA receptors in this process. Dr. Galanopoulou is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. Her top areas of expertise are West Syndrome, Spasmus Nutans, Post-Traumatic Epilepsy, and Epilepsy.

Jonathan M. Gursky, MD, is an Attending Physician at Montefiore and Assistant Professor of Neurology at our Albert Einstein College of Medicine. His clinical focus is on the diagnosis and treatment of adults and adolescents with epilepsy and seizure disorders. Dr. Gursky is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. His top areas of expertise are Seizures, Generalized Tonic-Clonic Seizure, West Syndrome, and Epilepsy.

Victor Ferastraoaru is a Neurologist in Bronx, New York. Dr. Ferastraoaru is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. His top areas of expertise are Seizures, Generalized Tonic-Clonic Seizure, Epilepsy, and Memory Loss.

Cigdem Akman is a Pediatric Neurologist in New York, New York. Dr. Akman is rated as an Advanced provider by MediFind in the treatment of Status Epilepticus. Her top areas of expertise are Seizures, Epilepsy, Status Epilepticus, and Generalized Tonic-Clonic Seizure.

Dr. Hyunmi Choi is an Associate Professor of Neurology at Columbia University Irving Medical Center and a board-certified epilepsy specialist with over 25 years of experience. She provides expert care in adult epilepsy and serves as an oversight neurologist for the intraoperative neuromonitoring service at NewYork-Presbyterian Hospital.Dr. Choi graduated Cum Laude from the SUNY Health Science Center at Syracuse. She completed both her neurology residency and fellowship in epilepsy/clinical neurophysiology at Columbia University Medical Center. She later earned a Master's in Biostatistics to support her research on patient-centered outcomes in epilepsy.Her NIH-funded research focuses on how vascular risk factors contribute to the link between late-onset epilepsy and subsequent stroke or dementia. She has been recognized as a Castle Connolly Top Doctor annually since 2015. Dr. Choi is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. Her top areas of expertise are Epilepsy, Seizures, Generalized Tonic-Clonic Seizure, Memory Loss, and Carotid Artery Surgery.

Dr. Winawer's clinical and research interests are in the genetics of epilepsy and Long COVID. Her research focuses on identifying genetic contributions to human health and disease with a focus on epilepsy, incorporating expertise in genetic epidemiology, human translational neuroscience, animal models, and imaging. Her recent work has led to the identification of the emerging role of somatic brain localized mutations in individuals with intractable focal epilepsy. Clinically, since the beginning of the COVID-19 pandemic, Dr. Winawer has become CUIMC’s expert in the neurological care of individuals with lasting sequelae of COVID-19, and in collaboration with the department of Infectious Disease, she has helped to form a multidisciplinary foundation-funded center for care and research of infection associated chronic conditions (IACCS) including Long COVID. Dr. Winawer is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. Her top areas of expertise are Epilepsy, Seizures, Partial Familial Epilepsy, and West Syndrome.

Carl Bazil completed his undergraduate studies at the Massachusetts Institute of Technology, followed by a combined MD/PhD program at Emory University, with a doctorate in pharmacology. He was a resident and chief resident in Neurology at New York University, and completed his fellowship in Epilepsy/EEG at the Neurological Institute of New York.He was then Assistant Professor of Neurology at Mount Sinai School of Medicine. Since 1996, he has been an attending neurologist at Columbia University Division of Epilepsy and Sleep Disorders, and was Director of the division from 2008-2021.  He has done extensive research in the relationship between epilepsy and sleep and in development of antiseizure drugs, and continues to evaluate patients with epilepsy and sleep disorders. Dr. Bazil is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. His top areas of expertise are Seizures, Memory Loss, Epilepsy, and Generalized Tonic-Clonic Seizure.

Kiran Thakur is a Neurologist in New York, New York. Dr. Thakur is rated as an Advanced provider by MediFind in the treatment of Status Epilepticus. Her top areas of expertise are Encephalitis, Meningitis, Tuberculous Meningitis, Gamma Knife Radiosurgery, and Awake Craniotomy.

Dr. Park is a Associate Professor of Neurology (in Biomedical informatics) at Columbia University Vagelos College of Physicians and Surgeons and Associate Attending Physician at NewYork-Presbyterian/Columbia University Irving Medical Center (NYP/CUIMC). Dr. Park received her undergraduate degree from Brown University and her medical degree from Drexel University College of Medicine. After completing her Neurology residency at Boston University Medical Center, she completed Stroke and Critical Care Neurology fellowships at the Massachusetts General & Brigham and Women's Hospitals.Dr. Park provides care for patients with acute brain and spine injury in the Neurological Intensive Care Unit at NYP/CUIMC. She is the Director of the Program for Hospital and Intensive Care Informatics. She is also the Medical Director of Critical Care Data Science and Artificial Intelligence for NewYork-Presbyterian Hospital. She is board certified in Neurology, Stroke, and Neurocritical Care. She is a Fellow of the American Heart Association and the Neurocritical Care Society. She serves as a board trustee for the Society for Complex Acute Illness and the Treasurer of the Neurocritical Care Society.Dr. Park’s research focuses on the development and clinical evaluation of innovative decision support tools in neurocritical care. Using continuous physiologic monitors and electronic medical record data, her work explores the optimal methods for creating predictive models to improve timeliness and precision in the diagnosis of preclinical syndromes in critical care. She was a recipient of an NIH K01 Career Development Award in Biomedical Big Data Science (Big Data to Knowledge, BD2K), and her research is now supported by the NINDS. Dr. Park is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. Her top areas of expertise are Subarachnoid Hemorrhage, Stroke, Increased Intracranial Pressure, Thrombectomy, and Gamma Knife Radiosurgery.

Dr. Roh is an Assistant Professor of Neurology at Columbia University Irving Medical Center. He is an Attending Neurointensivist Physician at NewYork-Presbyterian Hospital and joined as faculty in 2016. Prior to joining as faculty, Dr. Roh received his undergraduate degree from The University of Illinois at Urbana Champaign and his medical degree from Rush Medical College. He completed Neurology Residency at The University of Miami/Jackson Memorial Hospital followed by Neurocritical Care fellowship training at NewYork-Presbyterian: Columbia and Cornell Medical Centers. Dr. Roh is board certified in Neurology and Neurocritical Care and he specializes in the treatment of neurological emergencies and critical illness in the Neurosciences Intensive Care Unit.He is a clinical investigator whose research characterizes coagulopathy in critically ill patients, specifically in those who encounter brain bleeding.  Dr. Roh leads a translational research team whose focus is to develop novel laboratory diagnostic strategies and hemorrhage control therapy approaches to improve clinical outcomes in patients who encounter life threatening bleeding. His work is currently supported by the NIH (NINDS, NHLBI), the Department of Defense, and the National Blood Foundation. He currently serves as a senior advisory board member of the American Heart Association Hemorrhagic Stroke Science Committee. Dr. Roh is rated as an Experienced provider by MediFind in the treatment of Status Epilepticus. His top areas of expertise are Subarachnoid Hemorrhage, Stroke, Apoplexy, Noma, and Thrombectomy.